- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
KIMS Hospitals partners with UAIMS Hospital in Sangli

KIMS Partners with UAIMS Hospital in Sangali
Karad: Krishna Institute of Medical Sciences Ltd (KIMS) has announced an operations and management agreement with Ushahkal Abhinav Institute of Medical Sciences (UAIMS Hospital) in Sangli, Maharashtra, as part of its strategy to expand its healthcare presence.
The agreement, signed on February 17, 2025, spans an initial period of seven years, with an option to extend for an additional three years. Under the terms of the agreement, KIMS will have exclusive rights to provide medical services for both current and future operations of the hospital.
UAIMS, a state-of-the-art quaternary care facility, was founded in 2022 and boasts a capacity of 316 beds, with plans for future expansion to over 500 beds. The hospital is equipped with cutting-edge medical technology, including CT and MRI machines, 15 advanced operation theatres, and a dedicated mother and child care facility. The facility spans four acres, offering one of the highest floor-area-to-bed ratios in the region, and focuses heavily on critical care, providing more than 100 critical care beds with advanced medical infrastructure.
Also Read: KIMS acquires 100 per cent stake in 200-bed 'Queen's NRI Hospital' in Andhra Pradesh
According to Cnbctv18, UAIMS has also announced the launch of a comprehensive daycare oncology center adjacent to the hospital. This facility is currently under construction and is expected to be operationalized in 2025. KIMS will oversee the hospital’s full management, operations, and service delivery under the KIMS-UAIMS brand.
As part of the agreement, KIMS will receive 9% of the hospital’s net revenue. The partnership also includes a First Right of Refusal (ROFR) for KIMS and its affiliates to acquire profit-sharing from existing partners during the contract period. Additionally, KIMS has the option to acquire a majority profit share in UAIMS at its discretion.
KIMS has been actively expanding its presence in Maharashtra. In 2022, the company acquired Kingsway Hospital in Nagpur, followed by the launch of a second hospital in Nashik in 2024. KIMS is also planning to open a 300-bed multi-specialty hospital in Thane, scheduled to begin operations in the first quarter of the upcoming financial year.
Also Read: KIMS Hospital unveils state-of-the-art stroke centre
According to the news reports, despite the positive strategic developments, KIMS' stock saw a decline of 3.85%, closing at ₹558.70 on the Bombay Stock Exchange (BSE) on February 17, 2025.